19 results match your criteria: "The Retina Center at Pali Momi[Affiliation]"
Am J Ophthalmol Case Rep
March 2022
Hawaii Macula and Retina Institute, Aiea, HI, USA.
Introduction: Optic capture of sutured scleral fixated posterior chamber intraocular lenses (PC IOLs) is an occasional complication resulting in blurred vision and discomfort.
Methods: A retrospective study of the management of 18 eyes (3.6%) with optic capture out of 495 eyes with scleral fixated IOLs during the study period.
Hawaii J Health Soc Welf
November 2021
The Retina Center at Pali Momi, Aiea, HI (RTY,MLMY, GTK).
In February 2013, the Argus® II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, US) became the first "bionic eye" approved by the FDA to restore useful vision in patients previously blinded by end-stage retinitis pigmentosa, a hereditary, progressive degeneration of the outer retinal photoreceptor cells. The system captures and converts an external optical input into an electrical signal that activates an epiretinal electrode array on the inner surface of the retina.
View Article and Find Full Text PDFPurpose: To report a case of an 86-year-old man with a full thickness macular hole (FTMH) secondary to polypoidal choroidal vasculopathy (PCV) treated with bevacizumab.
Methods: A retrospective case report is presented.
Results: An 86-year-old male presented with a five-month history of metamorphopsia and decreased vision in his right eye and was found to have active exudation secondary to PCV with a concurrent FTMH.
Ophthalmol Retina
October 2021
University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii; Hawaii Macula and Retina Institute, Aiea, Hawaii; Retina Consultants of Hawaii, Aiea, Hawaii; The Retina Center at Pali Momi, Aiea, Hawaii.
Purpose: Although polypoidal choroidal vasculopathy (PCV) is best diagnosed with indocyanine green angiography (ICGA), ICGA is often unavailable or not ordered. OCT is widely available, and OCT B-scan can visualize polypoidal lesions diagnostic of PCV as inverted U-shaped elevations of the retinal pigment epithelium (RPE) with heterogeneous reflectivity and sometimes ring-shaped lesions within the polypoidal lesion. This study aims to differentiate findings between eyes diagnosed with PCV or typical exudative age-related macular degeneration (AMD) using ICGA and then compares findings noted on the OCT B-scan line scan in each group.
View Article and Find Full Text PDFPurpose: We report the longest follow-up to our knowledge of stable scleral fixation of a posterior chamber intraocular lens (PC IOL) with 10-0 polypropylene sutures.
Methods: A retrospective review is presented of a case with more than 30 years' follow-up after performing sutured scleral fixation with 10-0 polypropylene suture using 2 sutures tied together under a scleral flap. One suture was a cow-hitch looped around the haptic, and the other suture was passed through the sclera to create the scleral fixation.
Background/aims: To identify the clinical characteristics of polypoidal choroidal vasculopathy (PCV) in Caucasian patients and assess the prevalence of anti-vascular endothelial growth factor (anti-VEGF) resistance.
Methods: This involved a retrospective chart review of Caucasian patients diagnosed with PCV and utilizing indocyanine green angiography with the scanning laser ophthalmoscope. Data collected included patients' demographics, disease characteristics, and treatment response.
Ophthalmol Retina
September 2019
John A. Burns School of Medicine, University of Hawaii School of Medicine, Honolulu, Hawaii.
Purpose: To evaluate the prevalence of polypoidal choroidal vasculopathy (PCV) in different ethnic populations and to determine the prevalence of PCV in eyes with exudative age-related macular degeneration (AMD) that is sensitive and resistant to anti-vascular endothelial growth factor (VEGF) therapy.
Design: Retrospective chart review.
Participants: Two hundred fifty-three eyes of 221 patients with exudative AMD.
Retin Cases Brief Rep
September 2021
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
Purpose: To report patients who demonstrated an alteration in the clinical and optical coherence tomography features of neovascular age-related macular degeneration after resolution of endophthalmitis.
Methods: Retrospective case series of the subsequent changes in the macula and need for anti-vascular endothelial growth factor therapy in patients with neovascular age-related macular degeneration who developed endophthalmitis after intravitreal injection.
Results: The study included seven eyes of seven patients with follow-up ranging between 3 months and 11 years.
Retina
July 2019
John A. Burns School of Medicine, University of Hawaii School of Medicine, Honolulu, Hawaii.
Purpose: Determine sensitivity and specificity of polypoidal choroidal vasculopathy (PCV) diagnosis with structural en face optical coherence tomography (OCT) and OCT angiography (OCTA).
Methods: Retrospective review of the medical records of eyes diagnosed with PCV by indocyanine green angiography with review of diagnostic testing with structural en face OCT and OCTA by a trained reader. Structural en face OCT, cross-sectional OCT angiograms alone, and OCTA in its entirety were reviewed blinded to the findings of indocyanine green angiography and each other to determine if they could demonstrate the PCV complex.
Am J Ophthalmol
May 2018
The Retina Center at Pali Momi, Aiea, Hawaii; Retina Consultants of Hawaii, Aiea, Hawaii; Hawaii Macula and Retina Institute, Aiea, Hawaii.
Purpose: To assess the long-term stability of sutured scleral-fixated posterior chamber intraocular lenses (PCIOLs) performed in combination with pars plana vitrectomy.
Design: Retrospective, consecutive, interventional case series.
Methods: Retrospective single-surgeon study of 118 eyes of 111 patients seen at Retina Consultants of Hawaii, who underwent sutured scleral fixation of at least 1 haptic of a posterior chamber intraocular lens with 10-0 polypropylene combined with a pars plana vitrectomy.
Open Ophthalmol J
November 2017
The Retina Center at Pali Momi, 98-1079 Moanalua Road, Suite 470, Aiea, HI 96701, USA.
Purpose: To retrospectively review the prevalence of myopia and elongated axial length in eyes with polypoidal choroidal vasculopathy (PCV) and to evaluate treatment response of PCV in highly myopic eyes. PCV has rarely been reported in myopic eyes.
Methods: A retrospective review of all eyes diagnosed with PCV at the clinics of Retina Consultants of Hawaii and the Hawaii Macula and Retina Institute was performed between February of 2007 and April of 2017 to evaluate for eyes with significant myopia and elongated axial length.
Purpose: To compare the diagnostic ability of optical coherence tomography angiography (OCTA) with indocyanine green angiography (ICGA) in polypoidal choroidal vasculopathy (PCV).
Methods: Retrospective review of 47 eyes with PCV imaged with ICGA and OCTA. For each eye, it was determined which imaging modality better delineated the PCV complex.
BMC Ophthalmol
July 2016
John A. Burns School of Medicine, University of Hawaii School of Medicine, 651 Ilalo St, Honolulu, HI, 96813, USA.
Background: Polypoidal choroidal vasculopathy is a variant of choroidal neovascularization and neovascular age related macular degeneration presenting with hemorrhagic and exudative changes within the macula and/or peripapillary region leading to vision loss. In contrast to neovascular age related macular degeneration, polypoidal choroidal vasculopathy has differing clinical manifestations and treatment strategies. Historically, polypoidal choroidal vasculopathy complexes are less responsive to anti-vascular endothelial growth factor therapy with no prospective clinical trials evaluating aflibercept in management of polypoidal choroidal vasculopathy.
View Article and Find Full Text PDFJAMA Ophthalmol
May 2016
Genentech Inc, South San Francisco, California.
Importance: Understanding the range of temporal responses to ranibizumab is critical for the assessment of individualized treatment regimens for neovascular age-related macular degeneration.
Objective: To examine patterns of visual and anatomical response to ranibizumab treatment.
Design, Setting, And Participants: This study is a retrospective subanalysis of HARBOR (a phase 3, double-masked, multicenter, randomized, active treatment-controlled study of the efficacy and safety of 0.
Trans Am Ophthalmol Soc
July 2014
Division of Ophthalmology, Department of Surgery, University of Hawaii John A. Burns School of Medicine, Honolulu; Hawaii Macula and Retina Institute, Honolulu, an affiliation of Retina Consultants of Hawaii, Honolulu; and The Retina Center at Pali Momi, an affiliation of Hawaii Pacific Health, Aiea, Hawaii.
Purpose: The purpose of this study was to determine the following: (1) Is polypoidal choroidal vasculopathy (PCV) a subretinal neovascular process, rather than a choroidal vascular anomaly? and (2) Is a higher dose of ranibizumab (2.0 mg/0.05 mL) more effective in treating PCV than the current dose (0.
View Article and Find Full Text PDFOpen Ophthalmol J
November 2013
Division of Ophthalmology, Department of Surgery, University of Hawaii John A Burns School of Medicine, Honolulu, Hawaii; Retina Consultants of Hawaii, Honolulu, Hawaii, The Retina Center at Pali Momi, An Affiliation of Hawai'i Pacific Health, USA.
This 47 year old female developed the new onset of a polypoidal subretinal neovascular membrane in the left eye 13 years after having polypoidal choroidal vasculopathy (PCV) treated in the right eye. The indocyanine green (ICG) angiography of the left eye at initial presentation showed a normal choroidal vascular pattern without PCV. The new development of a PCV complex on ICG angiography demonstrates that PCV is truly a type of subretinal neovascularization, and not a choroidal vascular abnormality.
View Article and Find Full Text PDFRetin Cases Brief Rep
November 2014
From the *Division of Ophthalmology, Department of Surgery, University of Hawaii School of Medicine, Honolulu; and †The Retina Center at Pali Momi, an affiliation of Hawaii Pacific Health.
Purpose: To report the results of combined photodynamic therapy with verteporfin and intravitreal Avastin delivered on the same day in the treatment of juvenile subfoveal choroidal neovascularization.
Methods: Photodynamic therapy with Visudyne at standard fluence rates and intravitreal Avastin were successfully completed under topical anesthesia in a single day treatment session in an 11-year-old girl with subfoveal choroidal neovascularization.
Patient: A cooperative 11-year-old girl noted sudden vision loss in her right eye with a previous history of a small nonspecific extrafoveal inferior scar, and was noted to have developed an acute subfoveal choroidal neovascular membrane.
Ophthalmology
May 2004
The Retina Center at Pali Momi, Kapiolani Medical Center at Pali Momi, Aiea, Hawaii 96701, USA.
Purpose: To describe the clinical features and to present results of new diagnostic methods to help define the cause of the clinical syndrome of intrapapillary hemorrhage with adjacent peripapillary subretinal hemorrhage (IHAPSH).
Design: Retrospective review of patients with IHAPSH at presentation seen in 3 centers in Hawaii and Japan.
Methods: We analyzed data including patient demographics, presenting symptoms, initial and final visual acuities, biomicroscopic findings, fundus photographs, and results of available ancillary testing, including fluorescein angiography, B-scan ultrasonography, and optical coherence tomography.
Am J Ophthalmol
January 2001
The Retina Center at Pali Momi, Kapi'olani Health, Aiea, Hawaii, USA.
Purpose: To describe a modified technique of haptic externalization during repositioning of dislocated posterior chamber lens implants, which facilitates placement of scleral fixation sutures around the haptic for implant stabilization.
Methods: We describe a technique of repositioning a dislocated posterior chamber implant with scleral fixation sutures, which uses a small, clear corneal incision for externalization of the haptic. After a loop of 10-0 Prolene suture (Ethicon, Inc.